Skeletal muscle imaging biomarkers in GNE myopathy

Takeaway

  • Muscle involvement can be monitored, and disease severity determined non-invasively via use of magnetic resonance imaging (MRI) biomarkers in patients with GNE myopathy.

Why this matters

  • GNE myopathy is a rare degenerative disease characterized by slow-to-moderate progressive muscle weakness preferentially in the anterior tibialis, with early adult onset; and while there is no known treatment, any potential therapies will likely be most effective in earlier disease stages, which can be characterized by imaging techniques.

  • MRI biomarkers may constitute a non-invasive surveillance tool for GNE myopathy, both overall, and in clinical trials evaluating potential therapies for these patients.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.